Ellipse Technologies announced that for the first time since gaining 510(k) clearance from the U.S. Food and Drug Administration its MAGEC Spinal Bracing and Distraction System was successfully implanted in a progressive spinal deformity patient at Shriners Hospitals for Children — Philadelphia.
The system received FDA clearance for use in patients younger than 10 years of age with severe spinal deformities associated with, or at risk of, thoracic insufficiency syndrome. It provides an alternative to traditional growing rods.
The procedure was performed by Patrick Cahill, MD, and Harold van Bosse, MD, orthopedic surgeons at Shriners.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws